Infosys Elevates 12 Officials to Executive Vice Presidents
With the appointment of Vishal Sikka as CEO and managing director of the company, IT major Infosys has elevated 12 leaders to the position of executive vice president with additional responsibilities.
Among those who have made it to the list of executive vice presidents are CFO Rajiv Bansal; Sandeep Dadlani, along with the responsibilities as head, Retail, CPG and Logistics, and head of Americas; and Sanjay Jalona in addition to being head, Manufacturing & Engineering Services.
(See: Who Said What on Sikka's Appointment)
Mohit Joshi who is also made executive vice president will also function as head Financial Services and Infosys Brazil and Infosys Mexico, while Rajesh Krishnamurthy will be head, Energy & Communications and Services (Europe) and also head of Europe along with being EVP.
Infosys which announced the appointment of Sikka as new CEO and MD on June 12 had said that the company has elevated 12 leaders to the position of executive vice president with additional responsibilities.
(See: On Last Day at Infosys, Murthy Explains Rohan's Induction)
It had also elevated UB Pravin Rao, president and whole time director, as chief operating officer, with effect from June 14, 2014.
Sikka who has been inducted as a whole-time director of the board and CEO & MD (Designate) on June 14, 2014 will take over as CEO & MD from S D Shibulal on August 1, 2014.
Others who have made it to the list of Executive Vice President are Ranganath D Mavinakere with responsibilities of head, CEO's office and Corporate Center; Srikantan Moorthy- head, Human Resources and executive sponsor, Infosys Leadership Institute; Binod Hampapur Rangadore- head, Talent Fulfilment Function.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.